Mar 20, 2025 · 32m · a16z

Scaling Medicaid Innovation with Rajaie Batniji, Sanjay Basu, and Afia Asamoah

Rajaie Batniji · 10m spoken Vineeta Agarwala · 8m spoken Sanjay Basu · 6m spoken Afia Asamoah · 4m spoken
0:00 / 0:00
▶ Watch on YouTube →

gold bands on the timeline = statements, start to end. Hover to read, click to jump. CC turns on captions

In this panel discussion hosted by a16z's Vineeta Agarwala, Waymark co-founders Rajaie Batniji, Afia Asamoah, and Sanjay Basu detail how their public benefit corporation combines community-based care teams, predictive machine learning, and innovative value-based contracting to improve health outcomes and reduce costs for Medicaid populations.

How this conversation actually went

Every chapter scored 0–10 on four independent dynamics. Hover any point for the reasoning behind the score. How this is scored →

The host as informed peer 5.0 Guest teaching 4.1 Guest disagreement 0.9 The host pushing back 1.1
05100:0010:0020:0030:000:14–2:18 · The host as informed peer 3/10 Afia Asamoah's Background and Journey to Waymark Vineeta opens the interview by asking Afia about her background transitioning from law into health tech product development at Google. Afia provides a collaborative narrative about her career and motivation for joining Waymark.2:18–5:32 · The host as informed peer 4/10 Sanjay Basu on Clinical Practice and Social Interventions Vineeta frames Sanjay's dual role as clinical lead and practicing primary care physician before turning to Rajaie's background as a repeat founder. The exchange is warm and informative, establishing company origin stories.5:32–8:54 · The host as informed peer 4/10 The Care Delivery Model: Moving Care into Communities Vineeta notes that roughly 20-25 percent of Americans rely on Medicaid and gently questions how a tiny startup of three people could address such a daunting challenge. Rajaie explains that 39 percent of Medicaid acute care is avoidable and details how productizing community health worker interventions makes scaling possible.8:54–11:05 · The host as informed peer 3/10 Waymark's Structure as a Public Benefit Corporation Vineeta validates Waymark's product strategy before asking Afia to explain the choice to incorporate as a Public Benefit Corporation. Afia describes how a PBC structure binds leadership to a dual fiduciary and social charter.11:05–18:07 · The host as informed peer 5/10 NEJM Catalyst Study Results and Machine Learning Signal Vineeta introduces the New England Journal Catalyst study results and asks probing follow-up questions regarding clinical mechanics. Sanjay and Rajaie present trial results showing a 23 percent reduction in ER visits driven by machine learning risk prediction.18:07–21:25 · The host as informed peer 6/10 Defining and Targeting the Rising Risk Patient Population Vineeta pushes the guests on market friction, asking why other health groups fail to target rising-risk patients if the strategy is so obvious. Rajaie and Afia explain why legacy algorithms miss rising-risk cohorts and how risk-based contracting enables community care.21:25–26:42 · The host as informed peer 8/10 Participatory Data Science and AI Task Automation Vineeta demonstrates impressive domain mastery by connecting Waymark's machine learning model to biopharma clinical trial concepts like precision biomarkers and numbers needed to treat. Rajaie responds with a witty comment that if their model were a drug, withholding it would be medical malpractice.26:42–31:54 · The host as informed peer 7/10 Scaling Strategy, Value-Based Care, and Community Networks Vineeta actively builds on Rajaie's criticism of 'value veneers' in Medicaid, elaborating on how superficial ACO contracts lack actual care delivery resources. The guests discuss local community trust and wrap up the discussion.0:14–2:18 · Guest teaching 2/10 Afia Asamoah's Background and Journey to Waymark Vineeta opens the interview by asking Afia about her background transitioning from law into health tech product development at Google. Afia provides a collaborative narrative about her career and motivation for joining Waymark.2:18–5:32 · Guest teaching 3/10 Sanjay Basu on Clinical Practice and Social Interventions Vineeta frames Sanjay's dual role as clinical lead and practicing primary care physician before turning to Rajaie's background as a repeat founder. The exchange is warm and informative, establishing company origin stories.5:32–8:54 · Guest teaching 5/10 The Care Delivery Model: Moving Care into Communities Vineeta notes that roughly 20-25 percent of Americans rely on Medicaid and gently questions how a tiny startup of three people could address such a daunting challenge. Rajaie explains that 39 percent of Medicaid acute care is avoidable and details how productizing community health worker interventions makes scaling possible.8:54–11:05 · Guest teaching 3/10 Waymark's Structure as a Public Benefit Corporation Vineeta validates Waymark's product strategy before asking Afia to explain the choice to incorporate as a Public Benefit Corporation. Afia describes how a PBC structure binds leadership to a dual fiduciary and social charter.11:05–18:07 · Guest teaching 6/10 NEJM Catalyst Study Results and Machine Learning Signal Vineeta introduces the New England Journal Catalyst study results and asks probing follow-up questions regarding clinical mechanics. Sanjay and Rajaie present trial results showing a 23 percent reduction in ER visits driven by machine learning risk prediction.18:07–21:25 · Guest teaching 5/10 Defining and Targeting the Rising Risk Patient Population Vineeta pushes the guests on market friction, asking why other health groups fail to target rising-risk patients if the strategy is so obvious. Rajaie and Afia explain why legacy algorithms miss rising-risk cohorts and how risk-based contracting enables community care.21:25–26:42 · Guest teaching 4/10 Participatory Data Science and AI Task Automation Vineeta demonstrates impressive domain mastery by connecting Waymark's machine learning model to biopharma clinical trial concepts like precision biomarkers and numbers needed to treat. Rajaie responds with a witty comment that if their model were a drug, withholding it would be medical malpractice.26:42–31:54 · Guest teaching 5/10 Scaling Strategy, Value-Based Care, and Community Networks Vineeta actively builds on Rajaie's criticism of 'value veneers' in Medicaid, elaborating on how superficial ACO contracts lack actual care delivery resources. The guests discuss local community trust and wrap up the discussion.0:14–2:18 · Guest disagreement 0/10 Afia Asamoah's Background and Journey to Waymark Vineeta opens the interview by asking Afia about her background transitioning from law into health tech product development at Google. Afia provides a collaborative narrative about her career and motivation for joining Waymark.2:18–5:32 · Guest disagreement 0/10 Sanjay Basu on Clinical Practice and Social Interventions Vineeta frames Sanjay's dual role as clinical lead and practicing primary care physician before turning to Rajaie's background as a repeat founder. The exchange is warm and informative, establishing company origin stories.5:32–8:54 · Guest disagreement 1/10 The Care Delivery Model: Moving Care into Communities Vineeta notes that roughly 20-25 percent of Americans rely on Medicaid and gently questions how a tiny startup of three people could address such a daunting challenge. Rajaie explains that 39 percent of Medicaid acute care is avoidable and details how productizing community health worker interventions makes scaling possible.8:54–11:05 · Guest disagreement 0/10 Waymark's Structure as a Public Benefit Corporation Vineeta validates Waymark's product strategy before asking Afia to explain the choice to incorporate as a Public Benefit Corporation. Afia describes how a PBC structure binds leadership to a dual fiduciary and social charter.11:05–18:07 · Guest disagreement 1/10 NEJM Catalyst Study Results and Machine Learning Signal Vineeta introduces the New England Journal Catalyst study results and asks probing follow-up questions regarding clinical mechanics. Sanjay and Rajaie present trial results showing a 23 percent reduction in ER visits driven by machine learning risk prediction.18:07–21:25 · Guest disagreement 1/10 Defining and Targeting the Rising Risk Patient Population Vineeta pushes the guests on market friction, asking why other health groups fail to target rising-risk patients if the strategy is so obvious. Rajaie and Afia explain why legacy algorithms miss rising-risk cohorts and how risk-based contracting enables community care.21:25–26:42 · Guest disagreement 2/10 Participatory Data Science and AI Task Automation Vineeta demonstrates impressive domain mastery by connecting Waymark's machine learning model to biopharma clinical trial concepts like precision biomarkers and numbers needed to treat. Rajaie responds with a witty comment that if their model were a drug, withholding it would be medical malpractice.26:42–31:54 · Guest disagreement 2/10 Scaling Strategy, Value-Based Care, and Community Networks Vineeta actively builds on Rajaie's criticism of 'value veneers' in Medicaid, elaborating on how superficial ACO contracts lack actual care delivery resources. The guests discuss local community trust and wrap up the discussion.0:14–2:18 · The host pushing back 0/10 Afia Asamoah's Background and Journey to Waymark Vineeta opens the interview by asking Afia about her background transitioning from law into health tech product development at Google. Afia provides a collaborative narrative about her career and motivation for joining Waymark.2:18–5:32 · The host pushing back 0/10 Sanjay Basu on Clinical Practice and Social Interventions Vineeta frames Sanjay's dual role as clinical lead and practicing primary care physician before turning to Rajaie's background as a repeat founder. The exchange is warm and informative, establishing company origin stories.5:32–8:54 · The host pushing back 1/10 The Care Delivery Model: Moving Care into Communities Vineeta notes that roughly 20-25 percent of Americans rely on Medicaid and gently questions how a tiny startup of three people could address such a daunting challenge. Rajaie explains that 39 percent of Medicaid acute care is avoidable and details how productizing community health worker interventions makes scaling possible.8:54–11:05 · The host pushing back 0/10 Waymark's Structure as a Public Benefit Corporation Vineeta validates Waymark's product strategy before asking Afia to explain the choice to incorporate as a Public Benefit Corporation. Afia describes how a PBC structure binds leadership to a dual fiduciary and social charter.11:05–18:07 · The host pushing back 1/10 NEJM Catalyst Study Results and Machine Learning Signal Vineeta introduces the New England Journal Catalyst study results and asks probing follow-up questions regarding clinical mechanics. Sanjay and Rajaie present trial results showing a 23 percent reduction in ER visits driven by machine learning risk prediction.18:07–21:25 · The host pushing back 3/10 Defining and Targeting the Rising Risk Patient Population Vineeta pushes the guests on market friction, asking why other health groups fail to target rising-risk patients if the strategy is so obvious. Rajaie and Afia explain why legacy algorithms miss rising-risk cohorts and how risk-based contracting enables community care.21:25–26:42 · The host pushing back 2/10 Participatory Data Science and AI Task Automation Vineeta demonstrates impressive domain mastery by connecting Waymark's machine learning model to biopharma clinical trial concepts like precision biomarkers and numbers needed to treat. Rajaie responds with a witty comment that if their model were a drug, withholding it would be medical malpractice.26:42–31:54 · The host pushing back 2/10 Scaling Strategy, Value-Based Care, and Community Networks Vineeta actively builds on Rajaie's criticism of 'value veneers' in Medicaid, elaborating on how superficial ACO contracts lack actual care delivery resources. The guests discuss local community trust and wrap up the discussion.

speaking balance: gold is the host, purple is the guest (3 minute bins)

0:00 · the host 0% · guest 100%0:00 · the host 0% · guest 100%3:00 · the host 0% · guest 100%3:00 · the host 0% · guest 100%6:00 · the host 0% · guest 100%6:00 · the host 0% · guest 100%9:00 · the host 0% · guest 100%9:00 · the host 0% · guest 100%12:00 · the host 0% · guest 100%12:00 · the host 0% · guest 100%15:00 · the host 0% · guest 100%15:00 · the host 0% · guest 100%18:00 · the host 0% · guest 100%18:00 · the host 0% · guest 100%21:00 · the host 0% · guest 100%21:00 · the host 0% · guest 100%24:00 · the host 0% · guest 100%24:00 · the host 0% · guest 100%27:00 · the host 0% · guest 100%27:00 · the host 0% · guest 100%30:00 · the host 0% · guest 100%30:00 · the host 0% · guest 100%
Sharpest disagreement ▶ 26:37 Medical malpractice claim

Rajaie humorously reframes Vineeta's biopharma analogy with a provocative claim that withholding their non-drug intervention would constitute medical malpractice.

Hardest push from the host ▶ 20:15 Challenging market execution barriers

Vineeta directly challenges the guests on market reality by asking why other healthcare organizations fail to target rising-risk populations if the strategy is standard.

Biggest teaching moment ▶ 18:07 Flaws in traditional high-cost claimant algorithms

Rajaie educates the host on how standard Medicaid predictive algorithms identify high-cost patients only after their spend trajectory has already peaked and started declining naturally.

The host holds their own ▶ 25:23 Biopharma precision medicine parallel

Vineeta demonstrates high expertise by reframing the conversation using advanced pharma concepts like precision biomarkers and number needed to treat to evaluate AI model rigor.

the scores for every segment, with the reasoning behind each
ChapterTopicThe host as informed peerGuest teachingGuest disagreementThe host pushing backWhy
Afia Asamoah's Background and Journey to Waymark 3200 Vineeta opens the interview by asking Afia about her background transitioning from law into health tech product development at Google. Afia provides a collaborative narrative about her career and motivation for joining Waymark.
Sanjay Basu on Clinical Practice and Social Interventions 4300 Vineeta frames Sanjay's dual role as clinical lead and practicing primary care physician before turning to Rajaie's background as a repeat founder. The exchange is warm and informative, establishing company origin stories.
The Care Delivery Model: Moving Care into Communities 4511 Vineeta notes that roughly 20-25 percent of Americans rely on Medicaid and gently questions how a tiny startup of three people could address such a daunting challenge. Rajaie explains that 39 percent of Medicaid acute care is avoidable and details how productizing community health worker interventions makes scaling possible.
Waymark's Structure as a Public Benefit Corporation 3300 Vineeta validates Waymark's product strategy before asking Afia to explain the choice to incorporate as a Public Benefit Corporation. Afia describes how a PBC structure binds leadership to a dual fiduciary and social charter.
NEJM Catalyst Study Results and Machine Learning Signal 5611 Vineeta introduces the New England Journal Catalyst study results and asks probing follow-up questions regarding clinical mechanics. Sanjay and Rajaie present trial results showing a 23 percent reduction in ER visits driven by machine learning risk prediction.
Defining and Targeting the Rising Risk Patient Population 6513 Vineeta pushes the guests on market friction, asking why other health groups fail to target rising-risk patients if the strategy is so obvious. Rajaie and Afia explain why legacy algorithms miss rising-risk cohorts and how risk-based contracting enables community care.
Participatory Data Science and AI Task Automation 8422 Vineeta demonstrates impressive domain mastery by connecting Waymark's machine learning model to biopharma clinical trial concepts like precision biomarkers and numbers needed to treat. Rajaie responds with a witty comment that if their model were a drug, withholding it would be medical malpractice.
Scaling Strategy, Value-Based Care, and Community Networks 7522 Vineeta actively builds on Rajaie's criticism of 'value veneers' in Medicaid, elaborating on how superficial ACO contracts lack actual care delivery resources. The guests discuss local community trust and wrap up the discussion.

Statements from this episode (13)

Opinion
Agarwala: Every healthcare company could eventually resemble a consumer company
“As we've said on this podcast before, every healthcare company somewhere deep down could start to look like a consumer company.”
Vineeta Agarwala Mar 20, 2025 ▶ 2:18
Opinion
Batniji: Medicaid is US healthcare's largest and most addressable challenge
“All of the creativity, all the capital is going into largely Medicare and employer. And Medicaid is actually the biggest, and frankly, I think the most readily addressed challenge in, in US healthcare. And there was very little happening to take that on.”
Rajaie Batniji Mar 20, 2025 ▶ 4:32
Assertion Partly supported
Batniji: 39% of Medicaid acute care is avoidable, triple commercial rates
“40% of all acute care or 39% of all acute care in Medicaid is avoidable. That's like three times what it is in Medicare, three times what it is in commercial.”
Rajaie Batniji Mar 20, 2025 ▶ 6:48
Insight
Batniji: Missing software and funding models prevented community healthcare from scaling
“The challenge is nobody had ever built the product to reliably implement those proven interventions at scale, and nobody had ever created the funding mechanism to make those sustainable.”
Rajaie Batniji Mar 20, 2025 ▶ 7:41
Assertion Partly supported
Basu: Waymark improved Medicaid care quality metrics by 11 percentiles
“In addition to reducing emergency room visits by about a quarter versus that control group, we achieved a lot of improvement in access and quality outcomes. So nationally, they're measured by this Health Effectiveness Data Info System, or HEDIS, which a lot of…”
Sanjay Basu Mar 20, 2025 ▶ 15:07
Assertion Supported
Batniji: Waymark reduced Medicaid acute care by 23% and hospitalizations by 48%
“Reducing overall acute care in the intervene cohort by 23%, reducing what are called ambulatory care sensitive hospitalizations by 48%.”
Rajaie Batniji Mar 20, 2025 ▶ 16:30
Assertion Supported
Batniji: Standard Medicaid algorithms identify high-cost patients too late to help
“If you look at those high cost claimants, and you look at the algorithms that are used to identify them, there's a couple of very common ones, By the time they identify a patient, that patient's cost, and this is according to the National Medicaid Database, wh…”
Rajaie Batniji Mar 20, 2025 ▶ 18:33
Disclosure
Batniji: Waymark trains risk models on clinical and social data
“Our algorithm is, is trained not on cost or prior utilization, but on condition and social risk factors, and the various other data feeds that tell us about behavior, the kind of admission discharge transfer feeds, we can see whether they're picking up their m…”
Rajaie Batniji Mar 20, 2025 ▶ 19:16
Disclosure
Asamoah: Fee-for-service models fail to reimburse community-based healthcare
“Community based care is not reimbursed in a fee for service system, and so we are doing risk based contracting to make it work”
Afia Asamoah Mar 20, 2025 ▶ 20:53
Assertion Supported
Batniji: Waymark's ML model boosts acute care prediction accuracy to 90%
“If you didn't have signal, you'd have about 30% accuracy in identifying Future acute care use. I mean, seven out of the 10 patients that you reach out to, you're not going to actually benefit in a way that changes the outcome. With Signal, you have 90% accurac…”
Rajaie Batniji Mar 20, 2025 ▶ 24:00
Opinion
Batniji: Withholding Waymark's intervention would be medical malpractice if a drug
“I think the biggest difference is that if this were a drug, it'd be medical malpractice not to give it.”
Rajaie Batniji Mar 20, 2025 ▶ 26:38
Opinion
Batniji: Superficial value-based care agreements impede Medicaid delivery reform
“And I think that's actually been one of the biggest, like, challenges and impediments to adopting non-fee-for-service models in Medicaid is You know, the default mentality is, you know, if there is a value-based flag planted somewhere, then that territory is c…”
Rajaie Batniji Mar 20, 2025 ▶ 28:37
Insight
Basu: Healthcare delivery execution moves at the speed of local trust
“Yeah, you know, healthcare works at the speed of trust. So a lot of it happens through local relationships, and just getting to know folks, and showing up.”
Sanjay Basu Mar 20, 2025 ▶ 31:22
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 1,000 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.